InnovAge appoints Christine Bent as COO effective March 20, 2023; Maria Lozzano transitions to Senior Advisor
InnovAge Holding Corp.
Christine Bent appointed COO effective March 20, 2023; replaces Maria Lozzano who becomes Senior Advisor to CEO and COO through August 4, 2023.
Bent's employment agreement includes $455,000 base salary, 50% target bonus, $400,000 annual RSU grant, and initial $575,000 RSU grant vesting over 3 years.
Lozzano will receive base salary continuation for 12 months post-separation, pro-rata bonus, and healthcare coverage under transition agreement.
Bent previously SVP and COO at Prime Therapeutics; also held leadership roles at Allina Health and Atrius Health.
On March 1, 2023, InnovAge Holding Corp. (the “Company”) announced that its Board of Directors (the “Board”) has appointed Christine Bent as Chief Operations Officer of the Company effective March 20, 2023
Ms. Bent will replace Maria Lozzano, who will step down from her role as Chief Operating Officer, effective as of the Transition Date, and will remain employed by the Company as a Senior Advisor to Ms. Bent and the Company’s Chief Executive Officer.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Christine Bent was appointed as Chief Operations Officer at InnovAge Holding Corp..
Action
appointed
Role
Chief Operations Officer
Exact text from the filing
On March 1, 2023, InnovAge Holding Corp. (the “Company”) announced that its Board of Directors (the “Board”) has appointed Christine Bent as Chief Operations Officer of the Company effective March 20, 2023
Maria Lozzano changed role as Chief Operating Officer at InnovAge Holding Corp..
Action
step down
Role
Chief Operating Officer
Exact text from the filing
Ms. Bent will replace Maria Lozzano, who will step down from her role as Chief Operating Officer, effective as of the Transition Date, and will remain employed by the Company as a Senior Advisor to Ms. Bent and the Company’s Chief Executive Officer.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.